Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin‐resistant Helicobacter pylori infection

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Gastroenterology and Hepatology

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1440-1746.2003.03102.xPMID 12859730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppressive effect of Lactobacillus gasseri OLL2716 (LG21) on Helicobacter pylori infection in humans

  2004cited by this paper
• European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection. The Maasticht 2-2000 Consensus Report

  2002cited by this paper
• Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

  2002cited by this paper
• Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans.

  2001cited by this paper
• Induction of chemokine and cytokine responses by Helicobacter pylori in human stomach explants.

  2001cited by this paper
• Relationship between Eradication Therapy and Clarithromycin-resistant Helicobacter pylori in Japan

  2000cited by this paper
• Detection of Clarithromycin-ResistantHelicobacter pylori Strains by a Preferential Homoduplex Formation Assay

  2000cited by this paper
• Helicobacter pylori Caga Protein Can Be Tyrosine Phosphorylated in Gastric Epithelial Cells

  2000cited by this paper
• Clarithromycin resistance in Helicobacter pylori: implications for therapy.

  2000cited by this paper
• Water extract of Helicobacter pylori stimulates interleukin‐8 secretion by a human gastric epithelial cell line (JR‐St) through protein tyrosine phosphorylation

  2000cited by this paper
• Clarithromycin resistance in Helicobacter pylori: implications for therapy

  2000cited by this paper
• Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.

  1999cited by this paper
• The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

  1999cited by this paper
• Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model

  1998cited by this paper
• Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance

  1998cited by this paper
• vaccine in The Netherlands . persons vaccinated with inactivated poliovirus Poliovirus-specific immunoglobulin A in

  1997cited by this paper
• Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model.

  1997cited by this paper
• Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

  1997cited by this paper
• Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

  1996cited by this paper
• Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.

  1996cited by this paper
• Helicobacter pylori.

  1994cited by this paper
• Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8.

  1993cited by this paper
• The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

  1989cited by this paper
• Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro

  1989cited by this paper
• Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

  1989cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• In vivo Inhibition of Helicobacter pylori through Probiotics and Gastrointestinal Commensals: A Critical Review

  2025cites this paper
• Inhibitory Effects of Probiotic and Gastro-Intestinal Bacteria on Helicobacter pylori in vitro

  2025cites this paper
• Improving antagonistic effect of Lactobacillus gasseri MS-72 with herbal medicine extracts against pathogenic bacteria

  2025cites this paper
• Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance

  2024cites this paper
• Lactiplantibacillus plantarum ZJ316 Reduces Helicobacter pylori Adhesion and Inflammation by Inhibiting the Expression of Adhesin and Urease Genes.

  2023cites this paper
• Emerging parameters relevant to the management of antimicrobial‐resistant Helicobacter pylori infection

  2022cites this paper
• Lactobacillus plantarum ZJ316 Attenuates Helicobacter pylori-Induced Gastritis in C57BL/6 Mice.

  2021cites this paper
• Eradication therapy of helicobacteriosis with probiotics, problems, and prospects

  2021cites this paper
• Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections

  2021cites this paper
• Alimentos funcionales: Leches fermentadas con bacterias ácido lácticas productoras de exopolisacárido con propiedades antiinflamatorias en el tracto gastrointestinal

  2020cites this paper
• Comparative analysis of Lactobacillus gasseri from Chinese subjects reveals a new species-level taxa

  2020cites this paper
• The Rise of Nutraceuticals: Overview and Future

  2020cites this paper
• Effects of a Potential Probiotic Strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-Induced Inflammatory Response and Gene Expression in Coinfected Gastric Epithelial Cells

  2020cites this paper
• Disease managing capacities and mechanisms of host effects of lactic acid bacteria

  2020cites this paper
• Are probiotics useful for therapy of Helicobacter pylori diseases?

  2019cites this paper
• Lactobacillus gasseri Suppresses the Production of Proinflammatory Cytokines in Helicobacter pylori-Infected Macrophages by Inhibiting the Expression of ADAM17

  2019cites this paper
• Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells.

  2018cites this paper
• Lactobacillus fermentum UCO-979C beneficially modulates the innate immune response triggered by Helicobacter pylori infection in vitro.

  2018cites this paper
• A Modified Sequential Regimen of Helicobacterpylori Treatment Enforced by Bacillus clausii and Zinc Carnosine Complex Yields High Eradication Rates

  2017cites this paper
• Exopolysaccharide-producing Streptococcus thermophilus CRL1190 reduces the inflammatory response caused by Helicobacter pylori.

  2017cites this paper
• Antibacterial Activity of Lactic Acid Bacteria against Helicobacter pylori Evidence by in vivo and in vitro Studies

  2017cites this paper
• Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori.

  2016cites this paper
• Potential role of probiotics in the management of gastric ulcer

  2016cites this paper
• New insights into the bioactivity of peptides from probiotics.

  2016cites this paper
• Short communication: Modulation of the small intestinal microbial community composition over short-term or long-term administration with Lactobacillus plantarum ZDY2013.

  2016cites this paper
• Comparison of combination of probiotic and standard therapy compared to standard therapy on eradication of Helicobacter pylori infection in children

  2016cites this paper
• Amelioration of Helicobacter pylori -Induced PUD by Probiotic Lactic Acid Bacteria

  2016cites this paper
• Stabilization of Probiotics for Industrial Application

  2016cites this paper
• ALTERNATIVE THERAPIES BEYOND ANTIBIOTICS: HELICOBACTER PYLORI ERADICATION

  2015cites this paper
• The Gut Microbiome - Clinical Implications for the Practicing Gastroenterologist

  2015cites this paper
• In Vitro and In Vivo Anti-Helicobacter pylori Activity of Probiotics Isolated from Mongolian Dairy Products

  2015cites this paper
• Probiotics: an update.

  2015cites this paper
• Survival of Bifidobacterium longum and its effect on physicochemical properties and sensorial attributes of white brined cheese

  2014cites this paper
• Clinical application of probiotics in the treatment of Helicobacter pylori infection--a brief review.

  2014cites this paper
• Probiotics as cheater cells: parameter space clustering for individualized prescription.

  2014cites this paper
• Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism.

  2014cites this paper
• Editorial: Helicobacter pylori eradication therapy: advantages and disadvantages.

  2014cites this paper
• Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms

  2014cites this paper
• Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection

  2014cites this paper
• Cranberry extract suppresses interleukin-8 secretion from stomach cells stimulated by Helicobacter pylori in every clinically separated strain but inhibits growth in part of the strains

  2013cites this paper
• Probiotics: an alternative for cleaner production and a possible replacement of the antibiotics as growth promoters in animal feeding

  2013cites this paper
• Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health.

  2013cites this paper
• Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy

  2012cites this paper
• Antibacterial potentials of probiotics ; an explorable approach in therapeutic microbiology ?

  2012cites this paper
• “Is it effective?” to “How to use it?”: the era has changed in probiotics and functional food products against Helicobacter pylori infection

  2012cites this paper
• Meta-analysis: the Effect of Lactobacillus Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Treatment

  2012cites this paper
• Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone

  2011cites this paper
• Novel Probiotic Bifidobacterium bifidum CECT 7366 Strain Active against the Pathogenic Bacterium Helicobacter pylori

  2010cites this paper
• Yogurt Containing Lactobacillus gasseri OLL 2716 (LG21 yogurt) Accelerated the Healing of Acetic Acid-Induced Gastric Ulcer in Rats

  2010cites this paper
• Treatment of Helicobacter pylori infections: Mitigating factors and prospective natural remedies

  2010cites this paper
• Helicobacter pylori infection: efficacy of probiotics and role of genome wide association studies

  2010cites this paper
• Meta‐Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First‐Line Therapy for Helicobacter pylori Eradication

  2009cites this paper
• Herbs and Biological Agents

  2009cites this paper
• Dietary and socio-economic factors in relation to Helicobacter pylori re-infection.

  2009cites this paper
• Functional Dairy Products and Probiotics in Infectious Diseases

  2009cites this paper
• Commercially Available Human Probiotic Microorganisms

  2008cites this paper
• Agrifood Research Reports 131

  2008cites this paper
• Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells

  2008cites this paper
• Contribution of the Mannan Backbone of Cryptococcal Glucuronoxylomannan and a Glycolytic Enzyme of Staphylococcus aureus to Contact-Mediated Killing of Cryptococcus neoformans

  2007cites this paper
• [Antibiotic therapy with probiotics].

  2007cites this paper
• Antibioticoterapia con probióticos

  2007cites this paper
• ThE rol E of probio Tics in

  2007cites this paper
• Efficacy and Safety of Saccharomyces boulardii in the 14‐day Triple Anti‐Helicobacter pylori Therapy: A Prospective Randomized Placebo‐Controlled Double‐Blind Study

  2007cites this paper
• The role of probiotics in Helicobacter pylori infection

  2007cites this paper
• Treatment of Helicobacter pylori.

  2007cites this paper
• Probiyotik Bakterilerin Klinik Uygulamalarında Yeni Gelişmeler-I

  2006cites this paper
• ‘Rescue’ Therapies for the Management of Helicobacter pylori Infection

  2006cites this paper
• Properties of evidence-based probiotics for human health.

  2006cites this paper
• Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?

  2006cites this paper
• Environment as a Critical Factor for the Pathogenesis and Outcome of Gastrointestinal Disease: Experimental and Human Inflammatory Bowel Disease and Helicobacter-Induced Gastritis

  2006cites this paper
• Pre-biotic Effects of Sobo Drink on Colonization Resistance to Experimental Infection with Staphylococcus aureus 8588 in Rats

  2005cites this paper
• Probiotic and other functional microbes: from markets to mechanisms.

  2005cites this paper
• Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases.

  2005cites this paper
• Non-antibiotic therapies for Helicobacter pylori infection

  2005cites this paper
• Lactobacillus johnsonii La1 Attenuates Helicobacter pylori-Associated Gastritis and Reduces Levels of Proinflammatory Chemokines in C57BL/6 Mice

  2005cites this paper
• Chemokines in C 57 BL / 6 Mice and Reduces Levels of Proinflammatory-Associated Gastritis Helicobacter pylori La 1 Attenuates Lactobacillus johnsonii

  2005cites this paper
• Effects of a Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children: A Prospective Randomized Double-Blind Study

  2005cites this paper
• Probiotics and prebiotics in gastrointestinal disorders

  2004cites this paper
• Evolving therapy for Helicobacter pylori infection

  2004cites this paper
• 17 – Probiotics, prebiotics and gut health

  2004cites this paper
• Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against [correction of agaisnt] acute gastric lesion and antral ulcer in rats.

  2004cites this paper
• Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.

  2004cites this paper
• Therapy of Helicobacter pylori

  2004cites this paper
• Health Benefits of Probiotics: Probiotics for Helicobacter pylori Infection

  2004cites this paper